Organoids and Spheroids Market
完整報告名稱與涵蓋範圍
Organoids and Spheroids Market Research Report by Type (Organoids, Spheroids), by Source (Human Tissue, Animal Tissue, Synthetic), by Application (Drug Discovery, Toxicology Testing, Regenerative Medicine, Cancer Research, Stem Cell Research, Others), by End User (Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Centers, Research and Academic Institutions), and by Region (North America, Europe, Asia Pacific, South America, Middle East and Africa) Forecast till 2035
報告摘要
The Global Organoids and Spheroids Market was valued at USD 1,245.67 million in 2024 and is projected to reach USD 10,461.78 million by 2035. This remarkable growth reflects a strong CAGR of 22.05% during the forecast period, driven by increasing adoption in drug discovery and personalized medicine.
Rising Demand for Personalized Medicine
The focus on personalized medicine is really driving the Global Organoids and Spheroids Market forward. This is because organoids can be used to model diseases in a way that's specific to each patient, and to test drugs in a targeted way. Their ability to closely replicate human organ functionality enhances treatment precision and improves clinical outcomes.
Segment-Wise Market Breakdown
Type
• Organoids: Advanced 3D models mimicking human organ functions
• Spheroids: Simple cell clusters for basic biological studies
Source
• Human Tissue: Highly relevant models for personalized research applications
• Animal Tissue: Cost-effective models for preliminary experimental studies
• Synthetic: Engineered sources enabling scalable and controlled production
Application
• Drug Discovery: Accelerates identification of effective therapeutic compounds
• Toxicology Testing: Enables accurate assessment of drug safety profiles
• Regenerative Medicine: Supports development of tissue repair solutions
• Cancer Research: Facilitates tumor modeling and targeted therapy testing
• Stem Cell Research: Advances understanding of cell differentiation processes
• Others: Includes diverse emerging biomedical research applications
End User
• Pharmaceutical and Biotechnology Companies: Major adopters for drug development processes
• Hospitals and Diagnostic Centers: Utilize models for clinical and diagnostic insights
• Research and Academic Institutions: Drive innovation through extensive scientific studies
Regional Market Snapshot
North America is currently leading the way. This is due to the strong funding for research and development, the advanced biotech infrastructure, and the supportive regulatory environment. On the other hand, the Asia-Pacific region is growing the fastest, driven by government investments and the expanding contract research organization (CRO) sector. Europe is holding steady, while the Middle East, Africa, and South America are showing gradual growth, supported by innovation, healthcare needs, and cost-effective research models.
Strategic Product Innovation
For example, in July 2023, Molecular Devices LLC launched a custom organoid line expansion service. This service uses advanced bioprocess technology to support the production of organoids on a large scale, in a way that's efficient and scalable. One of the key advantages of the market is its ability to support personalized treatment approaches through models derived from patients.
Expanding Role in Personalized Medicine
The Global Organoids and Spheroids Market is poised for significant growth, driven by its ability to support personalized medicine and targeted therapy development. This capability allows for targeted therapy development, positioning organoids and spheroids as critical tools in next-generation healthcare solutions.
Key Report Attributes
• Market Size 2024: USD 1245.67 Million
• Market Size 2035: USD 10461.78 Million
• CAGR (2025-2035): 22.05%
• Base Year: 2024
• Market Forecast Period: 2025-2035
Industry Segmentations Growth
• By Type: Organoids - 22.39%, Spheroids - 21.56%.
• By Source: Human Tissue - 21.52%, Animal Tissue - 21.89%.
• By Application: Drug Discovery - 23.91%, Toxicology Testing - 19.03%.
• By End User: Pharmaceutical and Biotechnology Companies - 21.18%, Hospitals and Diagnostic Centers - 22.24%.
授權報價
| Single User Price | $4,950 USD |
| Multi User Licence (up to 10 users) | $5,950 USD |
| Enterprisewide Price (Global Site License) | $7,250 USD |
目錄 Table of Contents
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY ...... 18
2 MARKET INTRODUCTION ........ 20
2.1 DEFINITION ....... 20
2.2 SCOPE OF THE STUDY ....... 20
2.3 RESEARCH OBJECTIVE .......... 20
2.4 MARKET STRUCTURE ....... 21
3 RESEARCH METHODOLOGY ....... 22
3.1 OVERVIEW ......... 22
3.2 DATA FLOW ....... 24
3.2.1 DATA MINING PROCESS ......... 24
3.3 PURCHASED DATABASE: ....... 25
3.4 SECONDARY SOURCES: .......... 26
3.4.1 SECONDARY RESEARCH DATA FLOW: ......... 27
3.5 PRIMARY RESEARCH: ........ 28
3.5.1 PRIMARY RESEARCH DATA FLOW: ........ 29
3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED ........ 30
3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE ........ 30
3.6 APPROACHES FOR MARKET SIZE ESTIMATION: ...... 31
3.6.1 REVENUE ANALYSIS APPROACH ....... 31
3.7 DATA FORECASTING.......... 32
3.7.1 DATA FORECASTING TYPE ...... 32
3.8 DATA MODELING ....... 33
3.8.1 MICROECONOMIC FACTOR ANALYSIS: ........ 33
3.8.2 DATA MODELING: ......... 34
3.9 TEAMS AND ANALYST CONTRIBUTION ....... 36
4 MARKET DYNAMICS ...... 38
4.1 INTRODUCTION .......... 38
4.2 DRIVERS ......... 39
4.2.1 RISING DEMAND FOR PERSONALIZED MEDICINE ........ 39
4.2.2 DEMAND FROM DRUG DISCOVERY & TOXICOLOGY SCREENING ....... 39
4.2.3 ADVANCES IN 3D CULTURE PLATFORMS AND SUPPORTING TOOLS .......... 40
4.2.4 GROWTH IN R&D INVESTMENT & BIOTECH COLLABORATIONS ........ 40
4.3 RESTRAINTS .......... 41
4.3.1 REPRODUCIBILITY & STANDARDIZATION ISSUES ........ 41
4.3.2 REGULATORY CHALLENGES IMPACTING MARKET GROWTH ....... 42
4.3.3 HIGH COST OF DEVELOPMENT AND MAINTENANCE ........ 42
4.4 OPPORTUNITIES ........ 43
4.4.1 CONTRACT R&D / CRO SERVICES FOR ORGANOID ASSAYS ......... 43
4.4.2 PRECISION ONCOLOGY & PATIENT-DERIVED AVATAR TESTS .......... 44
4.5 CHALLENGES ......... 45
4.5.1 SCALING MANUFACTURING AND QC FOR COMMERCIAL-GRADE ORGANOIDS ...... 45
4.5.2 INTEGRATION CHALLENGES WITH EXISTING MEDICAL PRACTICES AND TECHNOLOGIES ........ 45
4.6 IMPACT ANALYSIS OF COVID-19 ....... 46
4.6.1 IMPACT ON GLOBAL ORGANOIDS AND SPHEROIDSS MARKET ........ 46
4.6.2 IMPACT ON SUPPLY CHAIN OF GLOBAL ORGANOIDS AND SPHEROIDS MARKET ....... 46
4.6.3 IMPACT ON PRICING GLOBAL ORGANOIDS AND SPHEROIDS MARKET ....... 46
5 INDUSTRY TREND ANALYSIS ...... 47
5.1 VALUE CHAIN ANALYSIS .......... 47
5.1.1 RAW MATERIAL SOURCING AND RESEARCH & DEVELOPMENT (R&D) ........ 47
5.1.2 ORGANOID/SPHEROID PRODUCTION AND QUALITY CONTROL/ASSURANCE ........ 47
5.1.3 DISTRIBUTION AND LOGISTICS ......... 48
5.1.4 APPLICATION IN RESEARCH, DRUG DISCOVERY, AND CLINICAL TRANSLATION ........ 48
5.2 PORTER'S FIVE FORCES MODEL ........ 49
5.2.1 THREAT OF NEW ENTRANTS ........ 49
5.2.2 BARGAINING POWER OF SUPPLIERS ...... 50
5.2.3 THREAT OF SUBSTITUTES ...... 50
5.2.4 BARGAINING POWER OF BUYERS ...... 50
5.2.5 INTENSITY OF RIVALRY .......... 50
6 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, BY TYPE ...... 52
6.1 OVERVIEW ......... 52
6.2 ORGANOIDS ........ 53
6.3 SPHEROIDS ........ 54
7 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE .......... 55
7.1 OVERVIEW ......... 55
7.2 HUMAN TISSUE ......... 56
7.3 ANIMAL TISSUE ........ 57
7.4 SYNTHETIC ....... 57
8 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION ....... 59
8.1 OVERVIEW ......... 59
8.2 DRUG DISCOVERY ...... 61
8.3 TOXICOLOGY TESTING ...... 61
8.4 REGENERATIVE MEDICINE ....... 62
8.5 CANCER RESEARCH ...... 62
8.6 STEM CELL RESEARCH .......... 63
8.7 OTHERS .......... 63
9 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, BY END USER ....... 65
9.1 OVERVIEW ......... 65
9.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES .......... 67
9.3 HOSPITALS AND DIAGNOSTIC CENTERS ...... 67
9.4 RESEARCH AND ACADEMIC INSTITUTIONS .......... 68
10 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, BY REGION ...... 69
10.1 OVERVIEW ......... 69
10.2 NORTH AMERICA ...... 70
10.2.1 US....... 73
10.2.2 CANADA ....... 74
10.3 EUROPE .......... 76
10.3.1 GERMANY .......... 79
10.3.2 FRANCE ........ 81
10.3.3 UK ...... 82
10.3.4 SPAIN ...... 84
10.3.5 ITALY ....... 85
10.3.6 RUSSIA ......... 87
10.3.7 REST OF EUROPE .......... 88
10.4 ASIA PACIFIC ......... 90
10.4.1 CHINA ...... 93
10.4.2 INDIA ....... 95
10.4.3 JAPAN .......... 97
10.4.4 SOUTH KOREA ......... 98
10.4.5 MALAYSIA ......... 100
10.4.6 THAILAND .......... 101
10.4.7 INDONESIA ......... 102
10.4.8 REST OF ASIA-PACIFIC ...... 104
10.5 SOUTH AMERICA ...... 106
10.5.1 BRAZIL .......... 109
10.5.2 MEXICO ........ 111
10.5.3 ARGENTINA ....... 112
10.5.4 REST OF SOUTH AMERICA ...... 114
10.6 MIDDLE EAST AND AFRICA ....... 116
10.6.1 GCC COUNTRIES...... 119
10.6.2 SOUTH AFRICA ........ 120
10.6.3 REST OF MEA .......... 122
11 COMPETITIVE LANDSCAPE ......... 125
11.1 INTRODUCTION .......... 125
11.2 MARKET SHARE ANALYSIS, 2024 ......... 125
11.3 COMPETITOR DASHBOARD........ 126
11.4 PUBLIC PLAYERS STOCK SUMMARY ........ 127
11.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL ........ 127
11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES ....... 127
11.6.1 PRODUCT LAUNCH ....... 127
12 COMPANY PROFILES ......... 128
12.1 MOLECULAR DEVICES LLC ........ 128
12.1.1 COMPANY OVERVIEW ........ 128
12.1.2 FINANCIAL OVERVIEW ....... 129
12.1.3 PRODUCTS/SERVICES OFFERED ........ 129
12.1.4 KEY DEVELOPMENTS ......... 129
12.1.5 KEY STRATEGIES .......... 129
12.2 MERCK KGGA ......... 130
12.2.1 COMPANY OVERVIEW ........ 130
12.2.2 FINANCIAL OVERVIEW ....... 131
12.2.3 PRODUCTS/SERVICES OFFERED ........ 132
12.2.4 KEY DEVELOPMENTS ......... 132
12.2.5 SWOT ANALYSIS .......... 132
12.2.6 KEY STRATEGIES .......... 133
12.3 CORNING INCORPORATED ......... 134
12.3.1 COMPANY OVERVIEW ........ 134
12.3.2 FINANCIAL OVERVIEW ....... 135
12.3.3 PRODUCTS OFFERED ......... 136
12.3.4 KEY DEVELOPMENTS ......... 136
12.3.5 SWOT ANALYSIS .......... 137
12.3.6 KEY STRATEGIES .......... 137
12.4 HUB ORGANOIDS ........ 138
12.4.1 COMPANY OVERVIEW ........ 138
12.4.2 FINANCIAL OVERVIEW ....... 139
12.4.3 PRODUCTS/SERVICES OFFERED ........ 139
12.4.4 KEY DEVELOPMENTS ......... 139
12.4.5 SWOT ANALYSIS .......... 140
12.4.6 KEY STRATEGIES .......... 140
12.5 STEMCELL TECHNOLOGIES ....... 141
12.5.1 COMPANY OVERVIEW ........ 141
12.5.2 FINANCIAL OVERVIEW ....... 142
12.5.3 PRODUCTS OFFERED ......... 142
12.5.4 KEY DEVELOPMENTS ......... 142
12.5.5 KEY STRATEGIES .......... 143
12.6 THERMO FISHER SCIENTIFIC INC. ......... 144
12.6.1 COMPANY OVERVIEW ........ 144
12.6.2 FINANCIAL OVERVIEW ....... 145
12.6.3 PRODUCTS OFFERED ......... 146
12.6.4 KEY DEVELOPMENTS ......... 146
12.6.5 SWOT ANALYSIS .......... 146
12.6.6 KEY STRATEGIES .......... 147
12.8.2 FINANCIAL OVERVIEW ....... 151
12.8.4 KEY DEVELOPMENTS ......... 152
12.8.5 SWOT ANALYSIS .......... 152
12.9 CN BIO INNOVATIONS LTD ........ 154
12.9.1 COMPANY OVERVIEW ........ 154
12.9.2 FINANCIAL OVERVIEW ....... 155
12.9.3 PRODUCTS OFFERED ......... 155
12.9.5 KEY STRATEGIES .......... 155
12.10 NEYROBLASTGX ........ 156
12.10.1 COMPANY OVERVIE ...... 156
12.10.2 FINANCIAL OVERVIEW ....... 156
12.10.3 PRODUCTS OFFERED ......... 157
12.10.5 KEY STRATEGIES .......... 157
13 DATA CITATIONS ...... 158
圖表清單 List of Tables & Figures
LIST OF TABLES
TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT 35
TABLE 2 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 53
TABLE 3 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, FOR ORGANOIDS, BY REGION, 2019–2035 (USD MILLION) 53
TABLE 4 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, FOR SPHEROIDS, BY REGION, 2019–2035 (USD MILLION) 54
TABLE 5 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 56
TABLE 6 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, FOR HUMAN TISSUE, BY REGION, 2019–2035 (USD MILLION) 56
TABLE 7 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, FOR ANIMAL TISSUE, BY REGION, 2019–2035 (USD MILLION) 57
TABLE 8 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, FOR SYNTHETIC, BY REGION, 2019–2035 (USD MILLION) 57
TABLE 9 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 60
TABLE 10 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, FOR DRUG DISCOVERY, BY REGION, 2019–2035 (USD MILLION) 61
TABLE 11 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, FOR TOXICOLOGY TESTING, BY REGION, 2019–2035 (USD MILLION) 61
TABLE 12 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, FOR REGENERATIVE MEDICINE, BY REGION, 2019–2035 (USD MILLION) 62
TABLE 13 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, FOR CANCER RESEARCH, BY REGION, 2019–2035 (USD MILLION) 62
TABLE 14 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, FOR STEM CELL RESEARCH, BY REGION, 2019–2035 (USD MILLION) 63
TABLE 15 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, FOR OTHERS, BY REGION, 2019–2035 (USD MILLION) 63
TABLE 16 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 66
TABLE 17 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2019–2035 (USD MILLION) 67
TABLE 18 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION, 2019–2035 (USD MILLION) 67
TABLE 19 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, FOR RESEARCH AND ACADEMIC INSTITUTIONS, BY REGION, 2019–2035 (USD MILLION) 68
TABLE 20 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, BY REGION, 2019-2035 (USD MILLION) 69
TABLE 21 NORTH AMERICA: ORGANOIDS AND SPHEROIDS MARKET, BY COUNTRY, 2019-2035 (USD MILLION) 71
TABLE 22 NORTH AMERICA: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 72
TABLE 23 NORTH AMERICA: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 72
TABLE 24 NORTH AMERICA: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 72
TABLE 25 NORTH AMERICA: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 73
TABLE 26 US: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 73
TABLE 27 US: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 73
TABLE 28 US: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 74
TABLE 29 US: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 74
TABLE 30 CANADA: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 74
TABLE 31 CANADA: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 75
TABLE 32 CANADA: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 75
TABLE 33 CANADA: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 76
TABLE 34 EUROPE: ORGANOIDS AND SPHEROIDS MARKET, BY COUNTRY, 2019-2035 (USD MILLION) 77
TABLE 35 EUROPE: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 78
TABLE 36 EUROPE: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 78
TABLE 37 EUROPE: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 79
TABLE 38 EUROPE: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 79
TABLE 39 GERMANY: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 79
TABLE 40 GERMANY: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 80
TABLE 41 GERMANY: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 80
TABLE 42 GERMANY: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 81
TABLE 43 FRANCE: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 81
TABLE 44 FRANCE: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 81
TABLE 45 FRANCE: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 82
TABLE 46 FRANCE: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 82
TABLE 47 UK: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 82
TABLE 48 UK: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 83
TABLE 49 UK: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 83
TABLE 50 UK: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 84
TABLE 51 SPAIN: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 84
TABLE 52 SPAIN: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 84
TABLE 53 SPAIN: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 85
TABLE 54 SPAIN: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 85
TABLE 55 ITALY: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 85
TABLE 56 ITALY: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 86
TABLE 57 ITALY: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 86
TABLE 58 ITALY: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 87
TABLE 59 RUSSIA: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 87
TABLE 60 RUSSIA: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 87
TABLE 61 RUSSIA: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 88
TABLE 62 RUSSIA: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 88
TABLE 63 REST OF EUROPE: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 88
TABLE 64 REST OF EUROPE: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 89
TABLE 65 REST OF EUROPE: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 89
TABLE 66 REST OF EUROPE: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 90
TABLE 67 ASIA PACIFIC: ORGANOIDS AND SPHEROIDS MARKET, BY COUNTRY, 2019-2035 (USD MILLION) 91
TABLE 68 ASIA PACIFIC: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 92
TABLE 69 ASIA PACIFIC: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 92
TABLE 70 ASIA PACIFIC: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 93
TABLE 71 ASIA PACIFIC: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 93
TABLE 72 CHINA: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 93
TABLE 73 CHINA: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 94
TABLE 74 CHINA: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 94
TABLE 75 CHINA: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 95
TABLE 76 INDIA: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 95
TABLE 77 INDIA: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 95
TABLE 78 INDIA: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 96
TABLE 79 INDIA: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 96
TABLE 80 JAPAN: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 97
TABLE 81 JAPAN: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 97
TABLE 82 JAPAN: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 97
TABLE 83 JAPAN: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 98
TABLE 84 SOUTH KOREA: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 98
TABLE 85 SOUTH KOREA: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 98
TABLE 86 SOUTH KOREA: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 99
TABLE 87 SOUTH KOREA: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 99
TABLE 88 MALAYSIA: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 100
TABLE 89 MALAYSIA: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 100
TABLE 90 MALAYSIA: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 100
TABLE 91 MALAYSIA: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 101
TABLE 92 THAILAND: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 101
TABLE 93 THAILAND: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 101
TABLE 94 THAILAND: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 102
TABLE 95 THAILAND: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 102
TABLE 96 INDONESIA: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 102
TABLE 97 INDONESIA: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 103
TABLE 98 INDONESIA: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 103
TABLE 99 INDONESIA: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 104
TABLE 100 REST OF ASIA-PACIFIC: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 104
TABLE 101 REST OF ASIA-PACIFIC: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 104
TABLE 102 REST OF ASIA-PACIFIC: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 105
TABLE 103 REST OF ASIA-PACIFIC: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 105
TABLE 104 SOUTH AMERICA: ORGANOIDS AND SPHEROIDS MARKET, BY COUNTRY, 2019–2035 (USD MILLION) 107
TABLE 105 SOUTH AMERICA: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 108
TABLE 106 SOUTH AMERICA: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 108
TABLE 107 SOUTH AMERICA: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 109
TABLE 108 SOUTH AMERICA: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 109
TABLE 109 BRAZIL: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 109
TABLE 110 BRAZIL: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 110
TABLE 111 BRAZIL: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 110
TABLE 112 BRAZIL: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 111
TABLE 113 MEXICO: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 111
TABLE 114 MEXICO: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 111
TABLE 115 MEXICO: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 112
TABLE 116 MEXICO: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 112
TABLE 117 ARGENTINA: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 112
TABLE 118 ARGENTINA: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 113
TABLE 119 ARGENTINA: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 113
TABLE 120 ARGENTINA: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 114
TABLE 121 REST OF SOUTH AMERICA: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 114
TABLE 122 REST OF SOUTH AMERICA: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 114
TABLE 123 REST OF SOUTH AMERICA: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 115
TABLE 124 REST OF SOUTH AMERICA: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION) 115
TABLE 125 MIDDLE EAST AND AFRICA: ORGANOIDS AND SPHEROIDS MARKET, BY COUNTRY, 2019–2035 (USD MILLION) 117
TABLE 126 MIDDLE EAST AND AFRICA: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION) 117
TABLE 127 MIDDLE EAST AND AFRICA: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION) 118
TABLE 128 MIDDLE EAST AND AFRICA: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION)
TABLE 129 MIDDLE EAST AND AFRICA: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION)
TABLE 130 GCC COUNTRIES: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION)
TABLE 131 GCC COUNTRIES: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION)
TABLE 132 GCC COUNTRIES: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION)
TABLE 133 GCC COUNTRIES: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION)
TABLE 134 SOUTH AFRICA: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION)
TABLE 135 SOUTH AFRICA: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION)
TABLE 136 SOUTH AFRICA: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION)
TABLE 137 SOUTH AFRICA: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION)
TABLE 138 REST OF MEA: ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2019–2035 (USD MILLION)
TABLE 139 REST OF MEA: ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2019–2035 (USD MILLION)
TABLE 140 REST OF MEA: ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2019–2035 (USD MILLION)
TABLE 141 REST OF MEA: ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2019–2035 (USD MILLION)
TABLE 142 PRODUCT LAUNCH
TABLE 143 MOLECULAR DEVICES, LLC: PRODUCTS/SERVICES OFFERED
TABLE 144 MOLECULAR DEVICES LLC: KEY DEVELOPMENTS
TABLE 145 MERCK KGAA: PRODUCTS/SERVICES OFFERED
TABLE 146 CORNING INCORPORATED: PRODUCTS/ SERVICE OFFERED
TABLE 147 HUB ORGANOIDS: PRODUCTS/SERVICES OFFERED
TABLE 148 STEMCELL TECHNOLOGIES: PRODUCTS OFFERED
TABLE 149 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
TABLE 150 BIO-TECHNE: PRODUCTS OFFERED
TABLE 152 CN BIO INNOVATIONS LTD: PRODUCTS OFFERED
TABLE 153 NEYROBLASTGX: PRODUCTS OFFERED
LIST OF FIGURES
FIGURE 1 GLOBAL ORGANOIDS AND SPHEROIDS MARKET: STRUCTURE 21
FIGURE 2 GLOBAL ORGANOIDS AND SPHEROIDS MARKET: MARKET GROWTH AFFECTING FACTOR ANALYSIS (2019-2035) 38
FIGURE 3 GLOBAL ORGANOIDS AND SPHEROIDS MARKET DRIVER: IMPACT ANALYSIS 41
FIGURE 4 GLOBAL ORGANOIDS AND SPHEROIDS MARKET RESTRAINT: IMPACT ANALYSIS 43
FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: GLOBAL ORGANOIDS AND SPHEROIDS MARKET 49
FIGURE 6 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, TYPE SEGMENT ATTRACTIVENESS, 2024 & 2035 (USD MILLION) 52
FIGURE 7 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, BY TYPE, 2024 & 2035 (USD MILLION) 52
FIGURE 8 GLOBAL ORGANOIDS AND SPHEROIDS MARKET SHARE (%), BY TYPE, 2024 54
FIGURE 9 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, SOURCE SEGMENT ATTRACTIVENESS, 2024 & 2035 (USD MILLION) 55
FIGURE 10 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, BY SOURCE, 2024 & 2035 (USD MILLION) 55
FIGURE 11 GLOBAL ORGANOIDS AND SPHEROIDS MARKET SHARE (%), BY SOURCE, 2024 58
FIGURE 12 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2024 & 2035 (USD MILLION) 59
FIGURE 13 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION, 2024 & 2035 (USD MILLION) 60
FIGURE 14 GLOBAL ORGANOIDS AND SPHEROIDS MARKET SHARE (%), BY APPLICATION, 2024 64
FIGURE 15 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, END USER SEGMENT ATTRACTIVENESS, 2024 & 2035 (USD MILLION) 65
FIGURE 16 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, BY END USER, 2024 & 2035 (USD MILLION) 66
FIGURE 17 GLOBAL ORGANOIDS AND SPHEROIDS MARKET SHARE (%), BY END USER, 2024 68
FIGURE 18 GLOBAL ORGANOIDS AND SPHEROIDS MARKET, BY REGION, 2024 & 2035 (USD MILLION) 69
FIGURE 19 GLOBAL ORGANOIDS AND SPHEROIDS MARKET SHARE (%), BY REGION, 2 024 70
FIGURE 20 NORTH AMERICA MARKET ANALYSIS: ORGANOIDS AND SPHEROIDS MARKET, 2019-2035 (USD MILLION) 70
FIGURE 21 NORTH AMERICA: ORGANOIDS AND SPHEROIDS MARKET, BY COUNTRY, 2024 & 2035 (USD MILLION) 71
FIGURE 22 NORTH AMERICA: ORGANOIDS AND SPHEROIDS MARKET SHARE (%), BY COUNTRY, 2024 71
FIGURE 23 EUROPE MARKET ANALYSIS: ORGANOIDS AND SPHEROIDS MARKET, 2019-2035 (USD MILLION) 76
FIGURE 24 EUROPE: ORGANOIDS AND SPHEROIDS MARKET, BY COUNTRY, 2024 & 2035 (USD MILLION) 77
FIGURE 25 EUROPE: ORGANOIDS AND SPHEROIDS MARKET SHARE (%), BY COUNTRY, 2024 78
FIGURE 26 ASIA PACIFIC MARKET ANALYSIS: ORGANOIDS AND SPHEROIDS MARKET, 2019-2035 (USD MILLION) 90
FIGURE 27 ASIA PACIFIC: ORGANOIDS AND SPHEROIDS MARKET, BY COUNTRY, 2024 & 2035 (USD MILLION) 91
FIGURE 28 ASIA PACIFIC: ORGANOIDS AND SPHEROIDS MARKET SHARE (%), BY COUNTRY, 2024 92
FIGURE 29 SOUTH AMERICA MARKET ANALYSIS: GLOBAL ORGANOIDS AND SPHEROIDS MARKET, 2019-2035 (USD MILLION) 106
FIGURE 30 SOUTH AMERICA: ORGANOIDS AND SPHEROIDS MARKET, BY COUNTRY, 2024 & 2035 (USD MILLION) 107
FIGURE 31 SOUTH AMERICA: ORGANOIDS AND SPHEROIDS MARKETSHARE, BY COUNTRY, 2024 (%) 108
FIGURE 32 MIDDLE EAST & AFRICA MARKET ANALYSIS: ORGANOIDS AND SPHEROIDS MARKET, 2019-2035 (USD MILLION) 116
FIGURE 33 MIDDLE EAST AND AFRICA: ORGANOIDS AND SPHEROIDS MARKETSHARE, BY COUNTRY, 2024 & 2035 (USD MILLION) 116
FIGURE 34 MIDDLE EAST AND AFRICA: ORGANOIDS AND SPHEROIDS MARKETSHARE, BY COUNTRY, 2024 (%) 117
FIGURE 35 GLOBAL ORGANOIDS AND SPHEROIDS MARKET PLAYERS: COMPETITIVE ANALYSIS, 2024 125
FIGURE 36 COMPETITOR DASHBOARD: GLOBAL ORGANOIDS AND SPHEROIDS MARKET 126
FIGURE 37 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT 131
FIGURE 38 MERCK KGGA: SWOT ANALYSIS 132
FIGURE 39 CORNING INCORPORATED: FINANCIAL OVERVIEW SNAPSHOT 135
FIGURE 40 CORNING INCORPORATED: SWOT ANALYSIS 137
FIGURE 41 HUB ORGANOIDS: SWOT ANALYSIS 140
FIGURE 42 THERMO FISHER SCIENTIFIC INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 43 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS
FIGURE 44 BIO-TECHNE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 45 3DNAMICS INC.: SWOT ANALYSIS
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們